Back to top
How Long Should You Own a Stock?

How Long Should You Own a Stock?

Even Warren Buffett would agree that not all stocks are meant to be held for a long time. Zacks Value Strategist Tracey Ryniec walks us through the process, complete with new recommendations.

loading...

CRISPR Science & Stocks: Knowing Enough to Invest

The past few months have provided plenty of excitement for Biotech investors as the three pure-play stocks of CRISPR technology have made some dramatic moves.

The past few months have provided plenty of ...

Previewing Q2 Earnings Season

Total Q2 earnings for the S&P 500 index are expected to be up +18.3% from the same period last year on +8% higher revenues, with 10 of the 16 Zacks sectors expected to have double-digit earnings growth.

Total Q2 earnings for the S&P 500 index ...

6 Small-Cap ETFs at 52-Week Highs with More Room Up

We highlight a few small-cap ETFs that have been hovering around their 52-week highs. They are also at their one-month highs and appear to be strong momentum plays.

We highlight a few small-cap ETFs that have ...

Investment Ideas

Stocks

ETFs

Mutual Funds

Options

Earnings Analysis

More Analysis

Earnings Headlines

View All

Reported Earnings Surprises

View All
Symbol Time Expected Reported %Surprise
MEI 06:49 0.75 0.98 +30.67
BYSI 07:20 -0.73 -0.61 +16.44
KR 07:41 0.63 0.73 +15.87
DRI 07:13 1.35 1.39 +2.96
PDCO 07:13 0.30 0.30 +0.00

EPS Positive Surprises for Jun 21, 2018

Symbol Time Expected Reported %Surprise

EPS Negative Surprises for Jun 21, 2018

Upcoming Earnings ESP

View More
Symbol ESP Most Accurate Estimate Consesus Estimate
NJR 3,700.00% 0.09 -0.00
QTWO 414.27% 0.04 0.01
TRGP 212.27% 0.09 -0.08

Video Commentaries

CRISPR Science and Stocks: Knowing Enough to Invest

CRISPR Science and Stocks: Knowing Enough to Invest

Can you learn enough about the science and the companies to invest with confidence? CRISPR Therapeutics: https://www.zacks.com/stock/quote/CRSP?cid=CS-YOUTUBE-FT-VID Editas Medicine: https://www.zacks.com/stock/quote/EDIT?cid=CS-YOUTUBE-FT-VID Intellia Therapeutics: https://www.zacks.com/stock/quote/NTLA?cid=CS-YOUTUBE-FT-VID Sangamo Therapeutics: https://www.zacks.com/stock/quote/SGMO?cid=CS-YOUTUBE-FT-VID Gilead Sciences: https://www.zacks.com/stock/quote/GILD?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch

Can you learn enough about the science and ...

Canada Legalizes Pot, Disney Outbids Comcast, & Micron Set to Report | Free Lunch | 6/20/18

Canada Legalizes Pot, Disney Outbids Comcast, & Micron Set to Report | Free Lunch | 6/20/18

On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney discusses the latest in the battle between Disney (DIS) and Comcast (CMCSA) to win over 21st Century Fox (FOXA) assets. He also previews Micron’s (MU) earnings report and discusses pot stocks like Cronos Group (CRON) in the wake of Canada’s marijuana legalization vote.

On today’s episode of Free Lunch, Associate ...

More Trump Tariffs, Small Cap Stocks, Earnings from ORCL & FDX | Free Lunch | 6/19/18

More Trump Tariffs, Small Cap Stocks, Earnings from ORCL & FDX | Free Lunch | 6/19/18

On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney discusses the latest trade war concerns causing volatility throughout global markets and speculates as to why small cap stocks have fared better in recent weeks. Later, he is joined by Zacks Strategist Dave Bartosiak to preview upcoming earnings reports from Oracle (ORCL) and FedEx (FDX).

On today’s episode of Free Lunch, Associate ...

Zacks Partner Headlines

thestreet

marketwatch

cnn